Estrogen-dependent side effects
The key and most clinically significant risk of taking COCs is thrombophilia. The estrogen component (most commonly ethinyl estradiol) actively interferes with the hemostatic system by stimulating the synthesis of blood clotting factors. This creates direct prerequisites for arterial and venous thrombosis, including deep vein thrombosis and pulmonary embolism (PE).
In healthy, non-smoking women, this process is counterbalanced by the compensatory activation of the fibrinolytic system, leaving overall blood coagulability virtually unchanged. However, in smoking patients, this protective mechanism is suppressed. Clinical conclusion: smoking is a strict contraindication for prescribing COCs due to a sharp spike in the risk of thromboembolism.
Other adverse estrogenic reactions include:
- Gastrointestinal disorders (nausea, vomiting).
- Neurological disturbances (headaches, dizziness).
- Fluid retention and edema (with the exception of medications containing drospirenone).
- Breast tenderness and skin rash.
- Visual disturbances.
- Intermenstrual spotting (especially when using micro-dose preparations).
Important: The development of hypercalcemia during drug administration requires its immediate discontinuation. Furthermore, prolonged estrogen monotherapy without the addition of progestogens significantly increases the risk of endometrial and breast cancer.
Progestogen-dependent side effects
The progestogen component of contraceptives is generally well tolerated by patients, though it also carries its own spectrum of adverse effects. General reactions include weight gain, edema, breast tenderness, as well as depressive states and decreased libido.
Specific effects directly depend on the chemical structure of the progestogen. 19-nortestosterone derivatives (levonorgestrel, norethisterone) possess pronounced androgenic activity, leading to:
- Acne and seborrhea.
- Development of hirsutism.
- Negative impact on the lipid profile (decrease in "good" HDL and increase in "bad" LDL).
Progestogens are also characterized by a high probability of irregular breakthrough bleeding. This occurs because, without an adequate amount of estrogen, the endometrium loses its ability to resist premature shedding.
Impact of the administration route on complication frequency
Oral administration of hormonal medications is inevitably associated with the first-pass hepatic effect. This means that achieving a therapeutic concentration in the blood requires higher daily doses, which naturally increases the risk of systemic side effects.
Alternative routes of administration (vaginal ring, transdermal patch) offer a number of pharmacokinetic advantages:
- Absence of hepatic metabolism during absorption allows for the use of lower steroid doses, minimizing adverse reactions.
- Smooth delivery of hormones into the systemic circulation throughout the day ensures stable menstrual cycle control without sharp concentration peaks.
- Reduced risk of user error (no need for daily pill intake).
Despite these benefits, the spectrum of indications, contraindications, and potential side effects for parenteral forms is entirely identical to that of classic COCs.
Duration of use and safety
There is a common misconception about the need to take breaks from hormonal contraceptives. Modern evidence confirms that with proper drug selection tailored to individual characteristics, COCs are completely safe for long-term use.
The duration of continuous use does not increase the risk of complications—preparations can be used right up until the onset of postmenopause. Conversely, unjustified breaks in use bring no health benefits while manifoldly increasing the risk of unintended pregnancy.
To remember common estrogenic side effects, use the acronym "THROMB": Thausea (Nausea), Retinal/Visual disorders, Oedema, Metrorrhagia (Uterine bleeding), Brainaches (Headache), and the main threat—thrombosis itself.
Class and exam questions
Why are COCs contraindicated in smoking women?
Estrogens stimulate the production of clotting factors. In non-smokers, this is compensated by the activation of fibrinolysis, whereas in smokers, this protective mechanism is diminished, critically increasing the risk of thromboembolism.
Is it necessary to take breaks from COCs to let the body "rest"?
No, when properly selected, preparations are safe right up to postmenopause. Breaks do not reduce the risk of complications, but sharply increase the likelihood of unintended pregnancy.
Which side effect requires immediate discontinuation of COCs?
The development of hypercalcemia is an absolute indication for emergency drug withdrawal.
Why do intermenstrual spotting occur?
When using pure progestogens or COCs with a very low estrogen dose, the endometrium loses the estrogen support that normally prevents its premature shedding.
What else to study on this topic
- Oral progestogen-only contraceptives ("minipills") and their use during lactation
- Long-acting injectable contraceptives
- Vaginal systems (NuvaRing) and their pharmacodynamics
- Transdermal therapeutic systems (Evra patch)
- Risks of estrogen monotherapy without progestogen cover
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "COC Side Effects" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.